Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Chronic Schizophrenia”

42 trials

Showing 20 of 42 results

Not applicableStudy completedNCT00161044
What this trial is testing

An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms

Who this might be right for
Chronic Schizophrenia
University of Maryland, Baltimore 20
Large-scale testing (Phase 3)Ended earlyNCT00216281
What this trial is testing

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

Who this might be right for
Schizophrenia
Indiana University 126
Not applicableStudy completedNCT06206798
What this trial is testing

Resourcefulness Group Intervention on Recovery and Quality of Life

Who this might be right for
Chronic SchizophreniaQuality of LifeRecovery
National Taipei University of Nursing and Health Sciences 40
Not applicableStudy completedNCT07183969
What this trial is testing

The Effectiveness of Lower Extremity Strength Training

Who this might be right for
Patients With Chronic Schizophrenia
National Taipei University of Nursing and Health Sciences 78
Not applicableStudy completedNCT04703530
What this trial is testing

Effect of Hot Footbath on the Sleep Quality

Who this might be right for
Schizophrenia
National Taipei University of Nursing and Health Sciences 66
Testing effectiveness (Phase 2)Study completedNCT00968851
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Who this might be right for
SchizophreniaCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 317
Large-scale testing (Phase 3)Study completedNCT00828958
What this trial is testing

Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53
Not applicableUnknownNCT02884739
What this trial is testing

Mental Healthcare in Older Adults With Schizophrenia

Who this might be right for
SchizophreniaChronic Psychiatric Disorder
CHU de Reims 685
Post-approval studies (Phase 4)Study completedNCT00761670
What this trial is testing

Efficacy Study on Cognitive Functions in Schizophrenic Patients

Who this might be right for
Schizophrenia
Sanofi 37
Large-scale testing (Phase 3)Study completedNCT00789698
What this trial is testing

Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Sumitomo Pharma America, Inc. 240
Testing effectiveness (Phase 2)Study completedNCT01163227
What this trial is testing

Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

Who this might be right for
Schizophrenia Disorders
Novartis Pharmaceuticals 57
Early research (Phase 1)Study completedNCT02411526
What this trial is testing

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Zogenix, Inc. 60
Not applicableStudy completedNCT04071444
What this trial is testing

Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum

Who this might be right for
Randomized Controlled Trial
National Yang Ming Chiao Tung University 112
Testing effectiveness (Phase 2)Study completedNCT00839852
What this trial is testing

Cariprazine in Patients With Chronic Stable Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 97
Testing effectiveness (Phase 2)Study completedNCT01450514
What this trial is testing

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

Who this might be right for
Chronic SchizophreniaSchizoaffective Disorder
PharmaNeuroBoost N.V. 7
Not applicableStudy completedNCT00540267
What this trial is testing

Bone Density in Patients With Schizophrenia

Who this might be right for
SchizophreniaAlcohol Abuse
Inje University 300
Early research (Phase 1)Study completedNCT00821600
What this trial is testing

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

Who this might be right for
Psychotic DisordersSchizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 24
Not applicableStudy completedNCT03497013
What this trial is testing

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Suzhou Psychiatric Hospital 64
Large-scale testing (Phase 3)Ended earlyNCT00148616
What this trial is testing

Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
M. Schaefer, MD 13
Not applicableStudy completedNCT02029989
What this trial is testing

Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

Who this might be right for
HyperlipidemiaDiabetesHypertension
University of Minnesota 121
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation